Who can take part?

You may be eligible if you:

• Are living with Mild Cognitive Impairment (MCI) or Alzheimer’s disease

• Are aged 50–85

• Have a family member or friend who knows you well and can attend visits with you

Who may not be eligible?

You may not be able to take part if, in the past 5 years, you have experienced:

• Seizures or epilepsy

• Alcohol or substance use disorder

• Stroke or other cerebrovascular disease

• Cancer (except certain treated types such as some skin cancers, in situ cervical cancer, or localised prostate cancer)

What does the trial involve?

• Brain scans (CT, PET or MRI)

• Study medication given via infusion

• Regular health monitoring and assessments

Key details

• Length of trial: Up to 2 years

• Visit frequency: Approximately 1 visit per month

• Trial type: Phase 2 clinical trial